Lifecore Biomedical, Inc. (LFCR)
6.38
-0.02
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:21
Lifecore Biomedical Net Income (Quarterly) : -40.08M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -40.08M |
| June 30, 2026 | -6.156M |
| March 31, 2026 | -14.98M |
| December 31, 2025 | |
| September 30, 2025 | |
| May 31, 2025 | -1.147M |
| February 28, 2025 | -14.77M |
| November 30, 2024 | -6.571M |
| August 31, 2024 | -16.23M |
| May 31, 2024 | -7.086M |
| February 29, 2024 | 14.78M |
| November 30, 2023 | 14.24M |
| August 31, 2023 | -12.61M |
| May 31, 2023 | -33.80M |
| February 28, 2023 | -11.33M |
| November 30, 2022 | -9.201M |
| August 31, 2022 | -6.707M |
| May 31, 2022 | -1.01M |
| February 28, 2022 | -6.638M |
| November 30, 2021 | 4.229M |
| August 31, 2021 | -7.633M |
| May 31, 2021 | -1.444M |
| February 28, 2021 | -1.465M |
| November 30, 2020 | -13.30M |
| August 31, 2020 | -11.00M |
| Date | Value |
|---|---|
| May 31, 2020 | -15.15M |
| February 29, 2020 | -11.52M |
| November 30, 2019 | -6.74M |
| August 31, 2019 | -4.784M |
| May 31, 2019 | 0.367M |
| February 28, 2019 | 1.533M |
| November 30, 2018 | -0.113M |
| August 31, 2018 | 0.335M |
| May 31, 2018 | 6.713M |
| February 28, 2018 | 16.28M |
| November 30, 2017 | 0.414M |
| August 31, 2017 | 2.355M |
| May 31, 2017 | 2.464M |
| February 28, 2017 | 3.494M |
| November 30, 2016 | 1.374M |
| August 31, 2016 | 3.345M |
| May 31, 2016 | 4.803M |
| February 29, 2016 | -21.17M |
| November 30, 2015 | 1.928M |
| August 31, 2015 | 2.988M |
| May 31, 2015 | 4.251M |
| February 28, 2015 | 3.803M |
| November 30, 2014 | 3.247M |
| August 31, 2014 | 2.424M |
| May 31, 2014 | 4.615M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | -- |
| Bruker Corp. | -109.70M |
| Azenta, Inc. | -1.529M |
| Danaher Corp. | 1.207B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 25.32M |
| Total Expenses (Quarterly) | 65.41M |
| EPS Diluted (Quarterly) | -1.084 |
| Enterprise Value | 432.87M |
| Gross Profit Margin (Quarterly) | 26.96% |
| Profit Margin (Quarterly) | -158.3% |
| Earnings Yield | -26.63% |